Követés
Ilona Kovalszky
Ilona Kovalszky
professor
E-mail megerősítve itt: med.semmelweis-univ.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Decorin–TGFβ axis in hepatic fibrosis and cirrhosis
K Baghy, RV Iozzo, I Kovalszky
Journal of Histochemistry & Cytochemistry 60 (4), 262-268, 2012
2052012
Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia
NG Than, R Romero, AL Tarca, KA Kekesi, Y Xu, Z Xu, K Juhasz, G Bhatti, ...
Frontiers in Immunology 9, 1661, 2018
2002018
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
L Otvos, E Haspinger, F La Russa, F Maspero, P Graziano, I Kovalszky, ...
BMC biotechnology 11, 1-14, 2011
1972011
Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression
A Fullár, J Dudás, L Oláh, P Hollósi, Z Papp, G Sobel, K Karászi, S Paku, ...
BMC cancer 15, 1-16, 2015
1532015
Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia …
NG Than, O Abdul Rahman, R Magenheim, B Nagy, T Fule, B Hargitai, ...
Virchows Archiv 453, 387-400, 2008
1512008
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer
J Tı́már, K Lapis, J Dudás, A Sebestyén, L Kopper, I Kovalszky
Seminars in Cancer Biology 12 (3), 173-186, 2002
1462002
Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar
T Várkonyi, B Nagy, T Füle, AL Tarca, K Karaszi, J Schönléber, P Hupuczi, ...
Placenta 32, S21-S29, 2011
1282011
Proteoglycans in liver cancer
K Baghy, P Tátrai, E Regős, I Kovalszky
World journal of gastroenterology 22 (1), 379, 2016
1252016
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
L Otvos Jr, I Kovalszky, M Riolfi, R Ferla, J Olah, A Sztodola, K Nama, ...
European journal of cancer 47 (10), 1578-1584, 2011
1252011
Placental protein 13 (PP13)–a placental immunoregulatory galectin protecting pregnancy
NG Than, A Balogh, R Romero, É Kárpáti, O Erez, A Szilágyi, I Kovalszky, ...
Frontiers in immunology 5, 348, 2014
1212014
Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice
K Baghy, K Dezső, V László, A Fullár, B Péterfia, S Paku, P Nagy, Z Schaff, ...
Laboratory investigation 91 (3), 439-451, 2011
1172011
Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis
G Lendvai, T Szekerczés, I Illyés, R Dóra, E Kontsek, A Gógl, A Kiss, ...
Pathology & Oncology Research 26, 3-15, 2020
1102020
Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas
C Lodi, E Szabo, A Holczbauer, E Batmunkh, A Szíjártó, P Kupcsulik, ...
Modern pathology 19 (3), 460-469, 2006
1082006
Expression of decorin, transforming growth factor-beta1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis
J Dudás, I Kovalszky, M Gallai, JO Nagy, Z Schaff, T Knittel, M Mehde, ...
American journal of clinical pathology 115 (5), 725-735, 2001
1052001
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
Z Lohinai, T Klikovits, J Moldvay, G Ostoros, E Raso, J Timar, K Fabian, ...
Scientific reports 7 (1), 39721, 2017
992017
Distinct epidemiology and clinical consequence of classic versus rare EGFR mutations in lung adenocarcinoma
Z Lohinai, MA Hoda, K Fabian, G Ostoros, E Raso, T Barbai, J Timar, ...
Journal of thoracic oncology 10 (5), 738-746, 2015
922015
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy
M Cserepes, G Ostoros, Z Lohinai, E Raso, T Barbai, J Timar, A Rozsas, ...
European journal of cancer 50 (10), 1819-1828, 2014
912014
Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma
A Fullár, I Kovalszky, M Bitsche, A Romani, VH Schartinger, GM Sprinzl, ...
Experimental cell research 318 (13), 1517-1527, 2012
892012
Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells
F Zong, E Fthenou, N Wolmer, P Hollosi, I Kovalszky, L Szilak, C Mogler, ...
PloS one 4 (10), e7346, 2009
892009
Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma
P Tátrai, J Dudás, E Batmunkh, M Máthé, A Zalatnai, Z Schaff, ...
Laboratory investigation 86 (11), 1149-1160, 2006
892006
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20